Ulsan City Provides Information on Prescription and Dispensing Institutions for COVID-19 Oral Medication
Prescription for Symptomatic High-Risk Groups and COVID-19 Patients
Ulsan City is currently providing information on oral COVID-19 treatment prescribing and dispensing institutions for the convenience of citizens as COVID-19 cases are resurging.
The city has also requested that prescribing institutions strictly confirm the eligibility criteria for COVID-19 treatments and the willingness of high-risk patients to take the medication before issuing prescriptions.
There are 228 prescribing institutions and 129 dispensing pharmacies for COVID-19 treatments in Ulsan. This information can be found on the Ulsan City website and the Infectious Disease Portal.
There are two types of oral COVID-19 treatments (Paxlovid and Lagevrio), which are used to treat mild cases in confirmed patients and to prevent severe progression in high-risk groups.
Prescriptions can be given to high-risk patients with symptoms, only after confirming their willingness to take the medication and if they meet both of the following criteria at the time of prescription.
The first criterion is: ▲ individuals aged 60 or older ▲ immunocompromised persons or those with underlying conditions aged 12 or older.
Immunocompromised persons include those undergoing treatment for tumors or hematologic cancers, individuals with congenital immunodeficiencies, lung transplant recipients, etc. Patients with underlying conditions include those with diabetes, hypertension, cardiovascular disease, chronic kidney disease, chronic lung disease, a body mass index (BMI) of 30kg/m² or higher, neurodevelopmental disorders, or mental illness.
The second criterion is: ▲ within 5 days of symptom onset ▲ patients who do not require oxygen therapy, and who meet both of these conditions.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Since May 1, due to the downgrade of the COVID-19 crisis level, free provision of COVID-19 treatments for high-risk groups has ended, and a minimum out-of-pocket cost is now required when receiving a prescription. However, medical aid recipients and those eligible for reduced out-of-pocket expenses will continue to receive the treatment free of charge.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.